Calithera Biosciences (NASDAQ:CALA) Coverage Initiated by Analysts at StockNews.com

Equities researchers at StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a report issued on Saturday. The firm set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

Shares of NASDAQ:CALA opened at $0.00 on Friday. Calithera Biosciences has a 1-year low of $0.00 and a 1-year high of $0.12.

Calithera Biosciences Company Profile

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.